MeMed raised €60M in a Series C round in Sep 2018. The company is based in Tirat Carmel, Israel. Investors in the round: Caesarea Medical Holdings, Clal Insurance, Foxconn and 6 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
